We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

85 hedge funds and large institutions have $109M invested in BioSpecifics Technologies Corp. in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 15 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

425% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 4

160% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 15

39% more capital invested

Capital invested by funds: $78.6M → $109M (+$30.6M)

25% more funds holding

Funds holding: 68 → 85 (+17)

Holders
85
Holders Change
+17
Holders Change %
+25%
% of All Funds
2.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
39
Reduced
15
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
+$2.57M
2
ECP
Elk Creek Partners
Colorado
+$2.44M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.31M
4
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$1.64M
5
RFC
Russell Frank Company
Washington
+$1.64M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$5.96M
2
RA
Royce & Associates
New York
-$1.45M
3
MCM
McKinley Capital Management
Alaska
-$1.19M
4
DCM
DAFNA Capital Management
California
-$1.01M
5
Franklin Resources
Franklin Resources
California
-$683K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.69M -$1.3K -34 -0.1%
PNC Financial Services Group
27
PNC Financial Services Group
Pennsylvania
$1.66M +$1.64M +43,039 New
Two Sigma Investments
28
Two Sigma Investments
New York
$1.44M +$998K +26,166 +236%
PI
29
Putnam Investments
Massachusetts
$1.41M -$7.78K -204 -0.6%
Invesco
30
Invesco
Georgia
$1.33M +$79.7K +2,090 +6%
State Street
31
State Street
Massachusetts
$1.3M +$87.1K +2,283 +7%
DCM
32
DAFNA Capital Management
California
$1.29M -$1.01M -26,588 -44%
BIM
33
Bogle Investment Management
Massachusetts
$1.28M +$1.27M +33,180 New
Geode Capital Management
34
Geode Capital Management
Massachusetts
$1.17M +$268K +7,036 +30%
Goldman Sachs
35
Goldman Sachs
New York
$1.15M +$734K +19,250 +183%
TCIM
36
TIAA CREF Investment Management
New York
$1.13M +$205K +5,376 +23%
BCM
37
Bridgeway Capital Management
Texas
$1.11M – – –
Two Sigma Advisers
38
Two Sigma Advisers
New York
$884K +$595K +15,600 +214%
TAM
39
Tocqueville Asset Management
New York
$772K -$191K -5,000 -20%
American Century Companies
40
American Century Companies
Missouri
$764K +$755K +19,778 New
RHJA
41
Rice Hall James & Associates
California
$758K -$99.4K -2,606 -12%
GA
42
Geneva Advisors
Illinois
$692K +$39.9K +1,047 +6%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$675K – – –
Citadel Advisors
44
Citadel Advisors
Florida
$530K -$33.1K -868 -6%
ACM
45
Ativo Capital Management
Illinois
$505K -$53.5K -1,402 -10%
BG
46
BlackRock Group
United Kingdom
$505K +$499K +13,069 New
HIM
47
Hillsdale Investment Management
Ontario, Canada
$482K -$38.2K -1,000 -7%
NA
48
Navellier & Associates
Nevada
$478K -$5.68K -149 -1%
DCM
49
Driehaus Capital Management
Illinois
$467K +$462K +12,100 New
SO
50
STRS Ohio
Ohio
$460K – – –
1
2
3 4

BSTC Hedge Fund Activity: Q4 2014 in Review

85 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2014, worth a combined $109M — up 39% from $78.6M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new BSTC positions and 4 closed out — a net gain of 17 holders — while 39 added to existing stakes and 15 trimmed.

The largest buyer was Numeric Investors, adding an estimated $2.57M. The largest seller was Deerfield Management, exiting entirely with an estimated $5.96M sold.

  • 85 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2014, up from 68 in Q3 2014.
  • Funds reported $109M of BioSpecifics Technologies Corp. stock for Q4 2014, up 39% quarter-over-quarter.
  • 21 funds opened new BioSpecifics Technologies Corp. positions in Q4 2014 and 4 closed out, a net change of +17 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2014 was Numeric Investors, an estimated $2.57M added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2014 was Deerfield Management, an estimated $5.96M sold.

Based on aggregated 13F filings for Q4 2014.